HIV specialist training available for nurse practitioners

HIV specialist training available for nurse practitioners
A new curriculum with specialized HIV training has been developed for nurse practitioners at the Johns Hopkins University School of Nursing.

(HealthDay)—A new curriculum with specialized HIV training has been developed for nurse practitioners (NPs) at the Johns Hopkins University School of Nursing (JHUSON).

Noting that patient outcomes are similar for HIV patients who receive care from a NP or a physician, the JHUSON has developed a new curriculum with a specialized training program option for NPs. The curriculum is expected to launch with 10 to 12 students enrolled.

The curriculum development is being funded by a five-year, $1.5 million grant from the Health Resources and Services Administration. The training module was placed in the NP degree program in response to current HIV care trends, which show that more care is moving out of specialized clinics and into primary care settings. The curriculum also extends the length of the field placement to one year. Students will be working in one of 20 sites, mainly in Baltimore and Washington, D.C. A key element involves sensitivity training that encourages students to identify preconceptions about the patient populations that they will be serving.

"The design of our program starts with the recognition that HIV care cannot be provided in a silo, that it needs to be integrated holistically into primary care," Jason Farley, Ph.D., M.P.H., developer of the curriculum, said in a statement. "We want our students to get this training right at the same time they're getting their advanced training in ."

More information: More Information

add to favorites email to friend print save as pdf

Related Stories

Trend-starting Texas drops algebra II mandate

Jan 25, 2014

Texas started a trend by making most of its high school students tackle algebra II. But eight years later, the state often watched for education policy is abandoning the requirement.

Recommended for you

The genetics of coping with HIV

7 hours ago

We respond to infections in two fundamental ways. One, which has been the subject of intensive research over the years, is "resistance," where the body attacks the invading pathogen and reduces its numbers. Another, which ...

Long acting HIV drugs to be developed

Sep 11, 2014

HIV drugs which only need to be taken once a month are to be developed at the University of Liverpool in a bid to overcome the problem of 'pill fatigue'.

Puerto Rico partners on US HIV vaccine project

Sep 10, 2014

Puerto Rico's governor says the island's largest public university is partnering with federal agencies to oversee a U.S.-funded project aimed at trying to develop a prophylactic vaccine for the HIV virus that causes AIDS.

User comments